Connect to other sites within the UBM Medica Network
Want to maximize the benefits and reduce potential harms of cervical cancer screening? Try these 4 strategies.
HPV Vaccine Achieves Population-Level Reduction of Cervical Cancer Lesions
In Denmark, researchers found that the risk of atypia, atypia+, and cervical intraepithelial neoplasia grade 2 or 3 (CIN2/3) were significantly reduced among women who received the vaccine.
HPV Vaccine: How Many Doses Are Really Needed?
Two doses of quadrivalent human papillomavirus (HPV) vaccine protects against genital warts nearly as well as the standard 3-dose schedule, according to new study findings.
Vaccine Treatments Trigger Cervical Lesions to Disappear
New research, led by Connie Trimble, MD, shows that vaccine treatments for women with high-grade cervical dysplasia can trigger an immune response that may induce some lesions to resolve.
HPV Vaccine Not Linked to Riskier Sexual Behaviors
The sexual behaviors and beliefs about HPV infection were unchanged among a group of teens and young women who were vaccinated against the virus, research shows.
Female Providers, Residents More Likely to Order HPV Testing for Low-Risk Women
Female providers were twice as likely as their male counterparts to order HPV testing for low-risk women aged 30 to 65 who had normal Pap smear results.
HPV Vaccination: Impact of Culture and Language on Initiation, Completion
English- and Spanish-speaking parents cited widely differing reasons for avoiding vaccination for their eligible daughters or failing to ensure the 3 doses were received.
Primary Care Physicians Play Key Role in Promoting HPV Vaccine to Boys' Parents
Most parents of boys aged 9 to 18 years do not know that an HPV vaccine is available for their sons. One major factor is a lack of information. This is where you play a vital role.